SCHEMBL7055476

SCHEMBL7055476

CC(=O)Nc1ccccc1C[O]

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
HPGD P15428 1/20 0.57
MAPK1 P28482 1/20 0.53
TSHR P16473 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HTT P42858 1/20 0.51
CYP2C19 P33261 2/20 0.50
POLB P06746 1/20 0.50
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
BRD4 O60885 1/20 0.47
HSD17B10 Q99714 2/20 0.47
NAPRT Q6XQN6 1/20 0.47
MAOA P21397 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17123632 0.86 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL1644965 0.86 MAPK1 (0.59) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL6970823 0.85 ALDH1A1 (0.53) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL3150784 0.84 ALDH1A1 (0.59) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL30168125 0.84 ALDH1A1 (0.59) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL1404979 0.83 ALDH1A1 (0.54) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL7236261 0.82 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL19924420 0.82 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL15591161 0.82 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL6475322 0.82 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP disclosed
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
CN-1284075-A Novel compounds having CGMP-PDE inhibitory effect MOCHIDA PHARM CO LTD (JP) 2001-02-14 CN disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed